Unlocking rare diseases with nanopore sequencing

In this talk recorded at ACMG 2026, Wendy Chung shares clinical research from Boston Children's Hospital's BEACON project. The research demonstrates the potential for Oxford Nanopore any-length reads to overcome limitations of short read sequencing and provide clarity on short-read negative rare disease samples.